Introduction In addition to the ongoing opioid crisis, cocaine use disorder continues to present as a public health issue and for which there are currently no Food and Drug Administration-approved pharmacotherapies
While some GLP-1 receptor agonists have FDA-approved cardiovascular risk reduction indications, tirzepatide does not currently have this indication, though cardiovascular outcome trials are ongoing
With over 15 years of experience, she blends science-based hormone and weight loss care with real-world compassion and clarity
In a retrospective analysis of 6050 patients with adult-onset GH deficiency, a significantly increased prevalence of diabetes has been reported (58)
See our guide on semaglutide alternatives for context
What this means: Insurance coverage will be critical Manufacturer savings programs will likely be available Access will be a significant barrier for many people Cost-effectiveness will be debated extensively The superior results might justify the cost for insurance companies